PeptidePedia The community reference

Revision history of Amylin

Page history·37 revisions·page 1 of 1

Revision history for Amylin. The list runs newest first. Byte counts are the size of the page source at that revision; the figure beside each is the change from the previous one. cur compares a revision with the current version, prev with the one before it.

37Revisions
28Distinct editors
5,795Current size (bytes)
28 Aug 2024Created

Most active on this page: TirzTaxonomist (3), CagriCass (2), SarcopeniaSefa (2), IcodecIndra (2), LiraLotte (2), TrialsTabitha (2).

  1. cur | prev 22:24, 15 Jul 2026 DulaglutideDug (talk | contribs) 5,795 bytes ±0 state the substitution in one-letter code as well, per PP:MOS
  2. cur | prev 03:00, 16 Jun 2026 CuriousCallum (talk | contribs) 5,795 bytes ±0 attribute the potency comparison to the head-to-head trial rather than to two separate ones [rollback]
  3. cur | prev 06:45, 27 May 2026 LiraLotte (talk | contribs) 5,795 bytes ±0 ce [rollback]
  4. cur | prev 14:09, 30 Apr 2026 CategoryBot (talk | contribs) 5,795 bytes ±0 m b bot: normalise citation format [rollback]
  5. cur | prev 18:27, 3 Apr 2026 CaptionCzeslaw (talk | contribs) 5,795 bytes ±0 rm a duplicated category [rollback]
  6. cur | prev 18:19, 3 Mar 2026 KPV_Kester (talk | contribs) 5,795 bytes ±0 rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  7. cur | prev 16:08, 10 Feb 2026 RetatrutideRuben (talk | contribs) 5,795 bytes ±0 add CAS number, sourced [rollback]
  8. cur | prev 20:34, 13 Jan 2026 MolarMassMaeve (talk | contribs) 5,795 bytes ±0 m expand §Physiology [rollback]
  9. cur | prev 12:34, 19 Dec 2025 TrialsTabitha (talk | contribs) 5,795 bytes ±0 m expand §Receptors [rollback]
  10. cur | prev 11:13, 25 Nov 2025 TitrationTheo (talk | contribs) 5,795 bytes ±0 m expand §Amyloid formation [rollback]
  11. cur | prev 13:53, 6 Nov 2025 AnalyticalAnnie (talk | contribs) 5,795 bytes ±0 m split overlong sentence [rollback]
  12. cur | prev 01:07, 8 Oct 2025 SarcopeniaSefa (talk | contribs) 5,795 bytes ±0 add the discontinued indication with its date [rollback]
  13. cur | prev 16:05, 17 Sep 2025 TirzTaxonomist (talk | contribs) 5,795 bytes +696 m move the trade-name history out of the lead and into §Regulatory history [rollback]
  14. cur | prev 22:29, 28 Aug 2025 CuriousCallum (talk | contribs) 5,099 bytes ±0 expand §Amyloid formation [rollback]
  15. cur | prev 10:51, 6 Aug 2025 DrTitration (talk | contribs) 5,099 bytes ±0 alphabetise the see-also list [rollback]
  16. cur | prev 12:19, 17 Jul 2025 AnalyticalAnnie (talk | contribs) 5,099 bytes +650 m state which salt form the mass in the infobox refers to [rollback]
  17. cur | prev 10:11, 22 Jun 2025 TirzTaxonomist (talk | contribs) 4,449 bytes +172 add the peptide length to the infobox [rollback]
  18. cur | prev 07:03, 3 Jun 2025 IcodecIndra (talk | contribs) 4,277 bytes +25 add see also to the amylin analogue [rollback]
  19. cur | prev 02:40, 11 May 2025 ApoB_Aurelio (talk | contribs) 4,252 bytes ±0 add the structural figure and caption it properly [rollback]
  20. cur | prev 12:19, 19 Apr 2025 LipidLedgerLou (talk | contribs) 4,252 bytes ±0 expand §Amyloid formation [rollback]
  21. cur | prev 09:43, 31 Mar 2025 Retention_Time_Rae (talk | contribs) 4,252 bytes ±0 serial comma per PP:MOS [rollback]
  22. cur | prev 07:07, 15 Mar 2025 Peptide_Pete (talk | contribs) 4,252 bytes ±0 add the molecular formula to the infobox [rollback]
  23. cur | prev 14:22, 24 Feb 2025 TrialsTabitha (talk | contribs) 4,252 bytes +296 reorder the analogues chronologically rather than alphabetically [rollback]
  24. cur | prev 23:50, 5 Feb 2025 LiraLotte (talk | contribs) 3,956 bytes +23 expand §Receptors [rollback]
  25. cur | prev 00:57, 17 Jan 2025 FmocFrancis (talk | contribs) 3,933 bytes +107 add category for the drug class [rollback]
  26. cur | prev 01:42, 4 Jan 2025 CagriCass (talk | contribs) 3,826 bytes +132 m state plainly that the research-use-only form is not approved for human use [rollback]
  27. cur | prev 11:25, 20 Dec 2024 MazdutideMads (talk | contribs) 3,694 bytes +456 m add the receptor targets to the lead sentence [rollback]
  28. cur | prev 18:40, 28 Nov 2024 DiffWatchDov (talk | contribs) 3,238 bytes ±0 close an unbalanced quotation mark [rollback]
  29. cur | prev 01:58, 18 Nov 2024 VerifyVesna (talk | contribs) 3,238 bytes +34 m the storage condition applies to the unopened pen; say so [rollback]
  30. cur | prev 06:14, 3 Nov 2024 UnitsUrsula (talk | contribs) 3,204 bytes ±0 give the strength per pen as well as per millilitre [rollback]
  31. cur | prev 16:23, 20 Oct 2024 IcodecIndra (talk | contribs) 3,204 bytes +639 m convert the substitution list to a table so the analogues line up [rollback]
  32. cur | prev 20:35, 11 Oct 2024 SurvodutideSaff (talk | contribs) 2,565 bytes +591 expand §Amyloid formation [rollback]
  33. cur | prev 07:46, 30 Sep 2024 SemaglutideSasha (talk | contribs) 1,974 bytes ±0 split §Pharmacology into receptor binding and downstream signalling [rollback]
  34. cur | prev 14:25, 19 Sep 2024 SarcopeniaSefa (talk | contribs) 1,974 bytes +705 add the year of first marketing authorisation, with the regulator named [rollback]
  35. cur | prev 17:13, 7 Sep 2024 CagriCass (talk | contribs) 1,269 bytes ±0 the half-life in the lead was the terminal figure; label it as such [rollback]
  36. cur | prev 07:33, 31 Aug 2024 StyleSheetSybil (talk | contribs) 1,269 bytes ±0 clarify that the peptide backbone is acylated rather than PEGylated [rollback]
  37. cur | prev 20:58, 30 Aug 2024 TirzTaxonomist (talk | contribs) 1,269 bytes +1,269 N start article on the compound [rollback]